Related Experiment Video
Updated: Jul 8, 2026

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Gene profiling uncovers retinoid target genes
Yan Ma1, Qing Feng, Ian Pitha-Rowe
1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH, USA.
Abstract:
Decades of hypothesis-driven research have identified candidate targets for cancer therapy and chemoprevention. Recently, genomic, proteomic, and tissue-based microarray approaches have made possible another scientific approach. This is one that interrogates comprehensively the complex profile of mRNA or protein expression present in normal, preneoplastic, or malignant cells and tissues. This in turn can uncover critical targets for cancer pharmacology and also lead to a better understanding of the known or novel networks of gene expression that play a rate-limiting role in carcinogenesis. This chapter addresses the use of mRNA expression profiling to uncover candidate target genes active in cancer pharmacology by citing as an example how this has already proven useful to reveal that retinoids (natural and synthetic derivatives of vitamin A) signal through pathways, which promote tumor cell differentiation, induce growth suppression, trigger apoptosis or affect other growth regulatory pathways. Pathways involved in the regulation of protein stability will be highlighted as these play a critical role in mediating pharmacological effects of the retinoids in cancer therapy or chemoprevention.
Insights
This study explores mRNA expression profiling to identify new cancer drug targets. It highlights how retinoids impact tumor cell differentiation and growth, emphasizing protein stability in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Traditional hypothesis-driven research has identified cancer therapy targets.
- Genomic and proteomic approaches now enable comprehensive interrogation of gene expression profiles.
Purpose of the Study:
- To explore mRNA expression profiling for uncovering novel cancer drug targets.
- To understand gene expression networks critical in carcinogenesis.
- To highlight the role of protein stability in retinoid-mediated cancer therapy.
Main Methods:
- Utilizing mRNA expression profiling to analyze gene expression in normal, preneoplastic, and malignant tissues.
- Examining retinoid signaling pathways involved in cancer regulation.
Main Results:
- mRNA expression profiling has successfully identified candidate genes for cancer pharmacology.
- Retinoids demonstrate significant effects on tumor cell differentiation, apoptosis, and growth suppression.
- Pathways regulating protein stability are crucial for retinoid efficacy in cancer treatment.
Conclusions:
- Comprehensive gene expression profiling is a powerful tool for discovering cancer drug targets.
- Retinoids offer therapeutic potential through pathways influencing cell fate and stability.
- Understanding gene networks and protein stability is key to advancing cancer pharmacology.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

